z-logo
open-access-imgOpen Access
Preparation and Evaluation of Chewable Tablets of Syzygium cumini Seed Powder
Author(s) -
Sushesh Srivatsa Palakurthi,
Deeksha Jakka,
Harpreeth Singh,
Sahithi Bollavaram,
B Sininandini,
Durga Nitya Pinnamraju,
Konde Abbulu
Publication year - 2020
Publication title -
journal of drug delivery and therapeutics
Language(s) - English
Resource type - Journals
ISSN - 2250-1177
DOI - 10.22270/jddt.v10i3.4069
Subject(s) - syzygium , phytochemical , gum acacia , chemistry , food science , traditional medicine , medicine , biochemistry
Aim of this study is to develop chewable tablets of Syzygium cumini seed powder. It has been chosen to do so as there are no oral solid dosage forms of this seed powder developed so far. There are numerous health benefits and nutrient properties of this seed powder, thus it can be used as a nutraceutical. Phytochemical screening of the Syzygium cumini seed powder has been conducted and the various phyto constituents present were detected. Seven different formulations have been developed by direct compression method out of which five were optimized. All these formulations were developed with Syzygium cumini seed powder as the active ingredient and lactose, acacia, glucose, talc, magnesium stearate, hydroxy propyl methyl cellulose, sodium alginate, guar gum and stevia were used as excipients. Various evaluations tests were performed to check the stability of the chewable tablets. Fourier Transform Infrared Spectroscopy (FTIR) analysis was conducted to check the interactions among the seed powder and the excipients. Anti-bacterial activity of the chewable tablets was tested against three different species of bacteria (Escherichia coli and Bacillus subtilis) by agar diffusion method. It is concluded that the Syzygium cumini seed powder and the developed chewable tablets were active against Escherichia coli and Bacillus subtilis.     Keywords: Syzygium cumini, Chewable tablet, anti-bacterial activity

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here